Eupraxia Pharmaceuticals Inc. (EPRX) stock
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.15+0.34 (+4.35%)
Close on Nov 13, 2026Market cap $491.40MP/E –Yield –
Eupraxia Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Eupraxia Pharmaceuticals's cash was $80.56M at Dec 31, 2025. For fiscal 2025 it was $80.56M, up 143.4% from the year before. The highest annual figure on record is $80.56M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.56M | +143.4% |
| FY2024 | Dec 31, 2024 | $33.10M | +71.1% |
| FY2023 | Dec 31, 2023 | $19.34M | +5.9% |
| FY2022 | Dec 31, 2022 | $18.26M | +45.8% |
| FY2021 | Dec 31, 2021 | $12.53M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $80.56M | +542.9% |
| Q4 FY2024 | Dec 31, 2024 | $33.10M | – |
| Q4 FY2023 | Dec 31, 2023 | $19.34M | – |
| Q4 FY2022 | Dec 31, 2022 | $18.26M | – |
| Q4 FY2021 | Dec 31, 2021 | $12.53M | – |
See a number that looks wrong?